FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904131086> ?p ?o ?g. }

• W2904131086 abstract "Chronic obstructive pulmonary disease (COPD, including bronchitis and emphysema) is a chronic condition causing shortness of breath, cough, and exacerbations leading to poor health outcomes. Face-to-face visits with health professionals can be hindered by severity of COPD or frailty, and by people living at a distance from their healthcare provider and having limited access to services. Telehealth technologies aimed at providing health care remotely through monitoring and consultations could help to improve health outcomes of people with COPD.To assess the effectiveness of telehealth interventions that allow remote monitoring and consultation and multi-component interventions for reducing exacerbations and improving quality of life, while reducing dyspnoea symptoms, hospital service utilisation, and death among people with COPD.We identified studies from the Cochrane Airways Trials Register. Additional sources searched included the US National Institutes of Health Ongoing Trials Register, the World Health Organization International Clinical Trials Registry Platform, and the IEEEX Xplore Digital Library. The latest search was conducted in April 2020. We used the GRADE approach to judge the certainty of evidence for outcomes.Eligible randomised controlled trials (RCTs) included adults with diagnosed COPD. Asthma, cystic fibrosis, bronchiectasis, and other respiratory conditions were excluded. Interventions included remote monitoring or consultation plus usual care, remote monitoring or consultation alone, and mult-component interventions from all care settings. Quality of life scales included St George's Respiratory Questionnaire (SGRQ) and the COPD Assessment Test (CAT). The dyspnoea symptom scale used was the Chronic Respiratory Disease Questionnaire Self-Administered Standardized Scale (CRQ-SAS).We used standard Cochrane methodological procedures. We assessed confidence in the evidence for each primary outcome using the GRADE method. Primary outcomes were exacerbations, quality of life, dyspnoea symptoms, hospital service utilisation, and mortality; a secondary outcome consisted of adverse events.We included 29 studies in the review (5654 participants; male proportion 36% to 96%; female proportion 4% to 61%). Most remote monitoring interventions required participants to transfer measurements using a remote device and later health professional review (asynchronous). Only five interventions transferred data and allowed review by health professionals in real time (synchronous). Studies were at high risk of bias due to lack of blinding, and certainty of evidence ranged from moderate to very low. We found no evidence on comparison of remote consultations with or without usual care. Remote monitoring plus usual care (8 studies, 1033 participants) Very uncertain evidence suggests that remote monitoring plus usual care may have little to no effect on the number of people experiencing exacerbations at 26 weeks or 52 weeks. There may be little to no difference in effect on quality of life (SGRQ) at 26 weeks (very low to low certainty) or on hospitalisation (all-cause or COPD-related; very low certainty). COPD-related hospital re-admissions are probably reduced at 26 weeks (hazard ratio 0.42, 95% confidence interval (CI) 0.19 to 0.93; 106 participants; moderate certainty). There may be little to no difference in deaths between intervention and usual care (very low certainty). We found no evidence for dyspnoea symptoms or adverse events. Remote monitoring alone (10 studies, 2456 participants) Very uncertain evidence suggests that remote monitoring may result in little to no effect on the number of people experiencing exacerbations at 41 weeks (odds ratio 1.02, 95% CI 0.67 to 1.55). There may be little to no effect on quality of life (SGRQ total at 17 weeks, or CAT at 38 and 52 weeks; very low certainty). There may be little to no effect on dyspnoea symptoms on the CRQ-SAS at 26 weeks (low certainty). There may be no difference in effects on the number of people admitted to hospital (very low certainty) or on deaths (very low certainty). We found no evidence for adverse events. Multi-component interventions with remote monitoring or consultation component (11 studies, 2165 participants) Very uncertain evidence suggests that multi-component interventions may have little to no effect on the number of people experiencing exacerbations at 52 weeks. Quality of life at 13 weeks may improve as seen in SGRQ total score (mean difference -9.70, 95% CI -18.32 to -1.08; 38 participants; low certainty) but not at 26 or 52 weeks (very low certainty). COPD assessment test (CAT) scores may improve at a mean of 38 weeks, but evidence is very uncertain and interventions are varied. There may be little to no effect on the number of people admitted to hospital at 33 weeks (low certainty). Multi-component interventions are likely to result in fewer people re-admitted to hospital at a mean of 39 weeks (OR 0.50, 95% CI 0.31 to 0.81; 344 participants, 3 studies; moderate certainty). There may be little to no difference in death at a mean of 40 weeks (very low certainty). There may be little to no effect on people experiencing adverse events (very low certainty). We found no evidence for dyspnoea symptoms.Remote monitoring plus usual care provided asynchronously may not be beneficial overall compared to usual care alone. Some benefit is seen in reduction of COPD-related hospital re-admissions, but moderate-certainty evidence is based on one study. We have not found any evidence for dyspnoea symptoms nor harms, and there is no difference in fatalities when remote monitoring is provided in addition to usual care. Remote monitoring interventions alone are no better than usual care overall for health outcomes. Multi-component interventions with asynchronous remote monitoring are no better than usual care but may provide short-term benefit for quality of life and may result in fewer re-admissions to hospital for any cause. We are uncertain whether remote monitoring is responsible for the positive impact on re-admissions, and we are unable to discern the long-term benefits of receiving remote monitoring as part of patient care. Owing to paucity of evidence, it is unclear which COPD severity subgroups would benefit from telehealth interventions. Given there is no evidence of harm, telehealth interventions may be beneficial as an additional health resource depending on individual needs based on professional assessment. Larger studies can determine long-term effects of these interventions." @default.
• W2904131086 created "2018-12-22" @default.
• W2904131086 creator A5013556651 @default.
• W2904131086 creator A5038022700 @default.
• W2904131086 creator A5074774824 @default.
• W2904131086 creator A5081957373 @default.
• W2904131086 creator A5082220804 @default.
• W2904131086 date "2021-07-20" @default.
• W2904131086 modified "2023-10-01" @default.
• W2904131086 title "Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD)" @default.
• W2904131086 cites W1522160754 @default.
• W2904131086 cites W1522381630 @default.
• W2904131086 cites W1609483777 @default.
• W2904131086 cites W1701934766 @default.
• W2904131086 cites W1748822485 @default.
• W2904131086 cites W1763173165 @default.
• W2904131086 cites W179122042 @default.
• W2904131086 cites W1940669997 @default.
• W2904131086 cites W1967112442 @default.
• W2904131086 cites W1970039259 @default.
• W2904131086 cites W1973378633 @default.
• W2904131086 cites W1973597670 @default.
• W2904131086 cites W1975679116 @default.
• W2904131086 cites W1979430749 @default.
• W2904131086 cites W1979518810 @default.
• W2904131086 cites W1981215269 @default.
• W2904131086 cites W1983702267 @default.
• W2904131086 cites W1984140720 @default.
• W2904131086 cites W1987305640 @default.
• W2904131086 cites W1989471922 @default.
• W2904131086 cites W2011161376 @default.
• W2904131086 cites W2013157268 @default.
• W2904131086 cites W2019637725 @default.
• W2904131086 cites W2028593694 @default.
• W2904131086 cites W2032257418 @default.
• W2904131086 cites W2040007302 @default.
• W2904131086 cites W2041071095 @default.
• W2904131086 cites W2041619279 @default.
• W2904131086 cites W2045468299 @default.
• W2904131086 cites W2052498711 @default.
• W2904131086 cites W2067616710 @default.
• W2904131086 cites W2069242782 @default.
• W2904131086 cites W2069502080 @default.
• W2904131086 cites W2072439195 @default.
• W2904131086 cites W2073349190 @default.
• W2904131086 cites W2074815806 @default.
• W2904131086 cites W2078289844 @default.
• W2904131086 cites W2079736485 @default.
• W2904131086 cites W2091099582 @default.
• W2904131086 cites W2095972104 @default.
• W2904131086 cites W2096932091 @default.
• W2904131086 cites W2098812160 @default.
• W2904131086 cites W2101849970 @default.
• W2904131086 cites W2109824141 @default.
• W2904131086 cites W2111374619 @default.
• W2904131086 cites W2112433656 @default.
• W2904131086 cites W2115186555 @default.
• W2904131086 cites W2115480924 @default.
• W2904131086 cites W2117798309 @default.
• W2904131086 cites W2118127048 @default.
• W2904131086 cites W2121606815 @default.
• W2904131086 cites W2122391940 @default.
• W2904131086 cites W2122691068 @default.
• W2904131086 cites W2134029019 @default.
• W2904131086 cites W2135060109 @default.
• W2904131086 cites W2135548587 @default.
• W2904131086 cites W2137219343 @default.
• W2904131086 cites W2138053189 @default.
• W2904131086 cites W2141960366 @default.
• W2904131086 cites W2142190824 @default.
• W2904131086 cites W2142485883 @default.
• W2904131086 cites W2143459670 @default.
• W2904131086 cites W2148296426 @default.
• W2904131086 cites W2154363280 @default.
• W2904131086 cites W2154722306 @default.
• W2904131086 cites W2155388082 @default.
• W2904131086 cites W2156098321 @default.
• W2904131086 cites W2156523739 @default.
• W2904131086 cites W2162454611 @default.
• W2904131086 cites W2163219465 @default.
• W2904131086 cites W2168501207 @default.
• W2904131086 cites W2169687817 @default.
• W2904131086 cites W2171767970 @default.
• W2904131086 cites W2271791695 @default.
• W2904131086 cites W2285434670 @default.
• W2904131086 cites W2296187073 @default.
• W2904131086 cites W2312821885 @default.
• W2904131086 cites W2317304226 @default.
• W2904131086 cites W2322909727 @default.
• W2904131086 cites W2328502012 @default.
• W2904131086 cites W2330095467 @default.
• W2904131086 cites W2331850013 @default.
• W2904131086 cites W2332582832 @default.
• W2904131086 cites W2334751008 @default.
• W2904131086 cites W2461336923 @default.
• W2904131086 cites W246286872 @default.
• W2904131086 cites W2470499034 @default.
• W2904131086 cites W2476481128 @default.
• W2904131086 cites W2494821474 @default.
• W2904131086 cites W2522718674 @default.

• next